Société Bristol-Myers Squibb Company Swiss Exchange

Société Bristol-Myers Squibb Company Swiss Exchange

BMY

US1101221083

Produits pharmaceutiques

Consensus des Analystes

Actions

BMY

US1101221083

Produits pharmaceutiques

Consensus des Analystes

Métier

Ventes par activité

Ventes par région

Dirigeants

Administrateurs

Classe d'actions

Actionnaires

Participations

Coordonnées société

Sociétés du groupe

Secteur

Ventes par région

Notations pour Bristol-Myers Squibb Company

Révisions de BNA

Bénéfices trimestriels - Taux de surprise

Secteur Pharmacies - Autres

Métier

Ventes par activité

Ventes par région

Dirigeants

Administrateurs

Classe d'actions

Actionnaires

Participations

Coordonnées société

Sociétés du groupe

Secteur

Ventes par région

Notations pour Bristol-Myers Squibb Company

Révisions de BNA

Bénéfices trimestriels - Taux de surprise

Secteur Pharmacies - Autres

Marché Fermé - Swiss Exchange Autres places de cotation 17:35:20 28/06/2019			Varia. 5j.	Varia. 1 janv.
44,39 ^CHF	-0,25%		-18,16%	-18,16%

19/06	Bristol Myers : l'ex-CEO d'Agilent rejoint le conseil	CF
18/06	Bristol Myers Squibb nomme Michael R. McMullen administrateur indépendant et membre du comité d'audit, à compter du 1er juillet 2024	CI

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.

70,1% du CA est réalisé aux Etats-Unis.

Nombre d'employés: 34 100

USD en Millions	2022	Poids	2023	Poids	Delta
Innovative Medicines 100,0 %	46 159	100,0 %	45 006	100,0 %	-2,50%

USD en Millions	2022	Poids	2023	Poids	Delta
United States 70,1 %	31 828	69,0 %	31 555	70,1 %	-0,86%
International 28,3 %	13 497	29,2 %	12 752	28,3 %	-5,52%
Other 1,6 %	834	1,8 %	699	1,6 %	-16,19%

Dirigeants	Titre	Age	Depuis
Christopher Boerner CEO	Chief Executive Officer	53	01/02/15
David Elkins DFI	Director of Finance/CFO	55	20/11/19
Greg Meyers CTO	Chief Tech/Sci/R&D Officer	-	-
Kimberly McCutcheon Jablonski CMP	Compliance Officer	-	01/01/03
Estelle Vester-Blokland CTO	Chief Tech/Sci/R&D Officer	-	-
Samit Hirawat CTO	Chief Tech/Sci/R&D Officer	55	01/01/19
Robert Plenge CTO	Chief Tech/Sci/R&D Officer	53	01/11/19
Laura Hortas IRO	Public Communications Contact	-	-
Cynthia Piccirillo PRN	Corporate Officer/Principal	-	-
Cari Gallman PRN	Corporate Officer/Principal	-	-

Administrateurs	Titre	Age	Depuis
Phyllis Yale BRD	Director/Board Member	66	20/11/19
Peter Arduini BRD	Director/Board Member	59	01/04/16
Derica Rice BRD	Director/Board Member	59	01/09/20
Paula Price BRD	Director/Board Member	62	01/09/20
Theodore Samuels BRD	Director/Board Member	69	21/02/17
David Elkins DFI	Director of Finance/CFO	55	20/11/19
Christopher Boerner CEO	Chief Executive Officer	53	01/02/15
Julia Haller BRD	Director/Board Member	69	20/11/19
Deepak Bhatt BRD	Director/Board Member	56	14/06/22
Karen Vousden BRD	Director/Board Member	66	01/01/18

	Vote	Nombre	Flottant	Autocontrôle	Flottant Total
Action A	1	2 923 100 096	2 024 918 592 ( 69,27 %)	896 000 000 ( 30,65 %)	69,27 %

Nom	Actions	%	Valorisation
Vanguard Fiduciary Trust Co. 9,179 %	186 067 109	9,179 %	7 645 M CHF
BlackRock Advisors LLC 6,184 %	125 355 772	6,184 %	5 151 M CHF
STATE STREET CORPORATION 4,517 %	91 571 110	4,517 %	3 763 M CHF
JPMorgan Investment Management, Inc. 4,367 %	88 525 438	4,367 %	3 638 M CHF
Capital Research & Management Co. (International Investors) 3,463 %	70 203 814	3,463 %	2 885 M CHF
Charles Schwab Investment Management, Inc. 2,650 %	53 715 966	2,650 %	2 207 M CHF
Fidelity Management & Research Co. LLC 2,099 %	42 557 702	2,099 %	1 749 M CHF
Geode Capital Management LLC 2,038 %	41 304 605	2,038 %	1 697 M CHF
BlackRock Life Ltd. 1,573 %	31 893 511	1,573 %	1 311 M CHF
Norges Bank (13F) 1,500 %	30 413 639	1,500 %	1 250 M CHF

Nom	Actions	%	Valorisation
Bram Bradesco Asset Management S/A DTVM 0,000338 %	6 843	0,000338 %	273 415 CHF

Nom	Actions	%	Valorisation
Transcend Wealth Collective LLC -	117 775	-	5 889 CHF
FourWorld Capital Management LLC -	100 000	-	5 000 CHF
Davenport & Co. LLC -	83 970	-	4 199 CHF
CapFinancial Partners LLC -	20 498	-	1 025 CHF
FIFTH THIRD BANCORP -	20 000	-	1 000 CHF
Private Advisor Group LLC -	15 000	-	750 CHF
Paradigm Financial Partners LLC -	10 000	-	500 CHF
Northwestern Mutual Wealth Management Co. -	242	-	12 CHF
OAKWORTH CAPITAL INC. -	125	-	6 CHF
Atlantic Edge Private Wealth Management LLC -	16	-	1 CHF

Nom	Actions	%	Valorisation
AVIDITY BIOSCIENCES, INC. 5,31%	5 075 304	5,31%	136 322 665 $
AVIDITY BIOSCIENCES, INC. 6,36%	759 145	6,36%	19 358 198 $
COMPUGEN LTD. 5,31%	4 757 058	5,31%	10 322 816 $
CELULARITY INC. 5,49%	1 195 327	5,49%	3 717 467 $

Bristol Myers Squibb Co.

Route 206 & Province Line Road

08543, Princeton

+609 252 4621

http://www.bms.com

Adresse Bristol-Myers Squibb Company(BMY)

Nom	Catégorie et Secteur
Bristol-Myers Squibb India Pvt Ltd. Bristol-Myers Squibb India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb India Pvt Ltd. is an Indian company that discovers, develops, and delivers medicines for immuno-oncology. The company is based in Mumbai, India.	Pharmaceuticals: Major
Bristol-Myers Squibb de México S de RL de CV Bristol-Myers Squibb de México S de RL de CV Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb de México S de RL de CV is a Mexican company that manufactures and supplies pharmaceutical and nutritional products. The company is located in Mexico.	Pharmaceuticals: Major
Celgene Kappa Holdings LLC
Bristol-Myers Squibb International Co. ULC
Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH
Seamair Insurance DAC Seamair Insurance DAC Insurance Brokers/ServicesFinance Part of Bristol Myers Squibb Co., Seamair Insurance DAC is an Irish company that provides insurance services. The company is based in Dublin, Ireland.	Insurance Brokers/Services
Bristol-Myers Squibb AE
Swords Laboratories Unlimited Co. Swords Laboratories Unlimited Co. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Swords Laboratories Unlimited Co. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Swords, Ireland.	Pharmaceuticals: Major
BMS Strategic Portfolio Investments Holdings, Inc.
Bristol-Myers Squibb (Finland) Oy Ab Bristol-Myers Squibb (Finland) Oy Ab Pharmaceuticals: GenericHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb (Finland) Oy Ab is a Finnish pharmaceutical manufacturing company. The company is based in Vantaa, Finland. The company was founded in 1974. Simone Böhrer has been the CEO of the company since 2020.	Pharmaceuticals: Generic
Celgene Alpine Investment Co. LLC
Bristol-Myers Squibb SARL Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France.	Medical Distributors
Celgene Alpine Investment Co. III LLC Celgene Alpine Investment Co. III LLC Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene Alpine Investment Co. III LLC is an American company that provides investment services. The company is located in the US.	Financial Conglomerates
Westwood-Intrafin SA
BMS Forex Co.
Bristol-Myers Squibb GmbH & Co. KGaA Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel.	Pharmaceuticals: Major
Bristol-Myers Squibb SA (Spain)
Bristol-Myers Squibb KK Bristol-Myers Squibb KK BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb KK develops, manufactures and markets biopharmaceutical products. The company is based in Shinjuku-ku, Japan.	Biotechnology
Bristol-Myers Squibb Australia Pty Ltd. Bristol-Myers Squibb Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Australia Pty Ltd. is a biopharmaceutical company that researches, develops and markets medicines for serious diseases. The company was founded in 1930 and is headquartered in Noble Park North, Australia.	Pharmaceuticals: Major
Bristol-Myers Squibb Belgium SA Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante.	Pharmaceuticals: Major
Bristol-Myers Squibb SRL Bristol-Myers Squibb SRL Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb SRL develops, manufactures and supplies pharmaceuticals. It offers diabetes, oncology, cardiovascular, neuroscience, virology, and immunology services. The company is headquartered in Rome, Italy.	Pharmaceuticals: Major
Bristol-Myers Squibb Pharmaceuticals Unlimited Co.
Bristol-Myers Squibb Canada Co. Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada.	Pharmaceuticals: Major
Bristol-Myers Squibb Holdings Ireland Unlimited Co. Bristol-Myers Squibb Holdings Ireland Unlimited Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Holdings Ireland Unlimited Co., a subsidiary of Bristol Myers Squibb Co., is a company headquartered in Ireland that operates as a holding company which develops medicines for serious diseases.	Pharmaceuticals: Major
JUNO THERAPEUTICS INC	Biotechnology
Bristol-Myers Squibb Pharmaceuticals Ltd. Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK.	Pharmaceuticals: Major
Bristol-Myers Squibb AB Bristol-Myers Squibb AB Medical DistributorsDistribution Services Part of Bristol Myers Squibb Co., Bristol-Myers Squibb AB is a company that wholesales medical equipment and pharmacy. The company is based in Solna, Sweden.	Medical Distributors
Bristol-Myers Squibb SA (Switzerland)

Note Trading

Note Investissement

ESG Refinitiv

Plus de notations

Vente

Achat

Recommandation moyenne

CONSERVER

Nombre d'Analystes

Dernier Cours de Cloture

41,04 USD

Objectif de cours Moyen

53,19 USD

Ecart / Objectif Moyen

+29,62%

Consensus

Révisions des Estimations

Agenda de la société

	Varia. 1 janv.	Capi.
ELI LILLY AND COMPANY	+51,99%	798 Md
JOHNSON & JOHNSON	-5,72%	356 Md
MERCK & CO., INC.	+18,94%	328 Md
ABBVIE INC.	+11,07%	304 Md
ASTRAZENECA PLC	+16,96%	244 Md
ROCHE HOLDING AG	+2,25%	227 Md
NOVARTIS AG	+11,15%	216 Md
AMGEN INC.	+7,59%	166 Md
PFIZER, INC.	-3,65%	157 Md

Pharmacies - Autres

Recherche pharmaceutique et médicale

Produits pharmaceutiques

Produits pharmaceutiques

Pharmacies - Autres